GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.30 $3.29 Thursday, 18th Apr 2024 ABUS stock ended at $2.73. This is 1.80% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.72% from a day low at $2.69 to a day high of $2.79.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
2021-08-10 $3.15 $3.26 $3.12 $3.14 1 871 194
2021-08-09 $3.07 $3.23 $3.04 $3.09 1 756 373
2021-08-06 $2.93 $3.06 $2.85 $3.01 894 626
2021-08-05 $2.79 $3.12 $2.77 $3.04 2 605 229
2021-08-04 $2.76 $2.85 $2.73 $2.76 867 791
2021-08-03 $2.75 $2.76 $2.67 $2.75 589 918
2021-08-02 $2.68 $2.74 $2.67 $2.71 673 125
2021-07-30 $2.74 $2.86 $2.68 $2.69 2 203 471
2021-07-29 $2.82 $2.89 $2.72 $2.76 2 448 803
2021-07-28 $2.72 $2.80 $2.69 $2.80 1 046 929
2021-07-27 $2.72 $2.73 $2.62 $2.70 675 369
2021-07-26 $2.79 $2.80 $2.69 $2.71 639 144
2021-07-23 $2.83 $2.83 $2.72 $2.76 753 954
2021-07-22 $2.99 $2.99 $2.78 $2.81 870 465
2021-07-21 $2.76 $3.00 $2.74 $2.94 1 719 762
2021-07-20 $2.74 $2.75 $2.61 $2.72 1 041 799
2021-07-19 $2.59 $2.71 $2.57 $2.71 1 135 482
2021-07-16 $2.66 $2.68 $2.59 $2.66 950 908
2021-07-15 $2.69 $2.72 $2.54 $2.65 877 708
2021-07-14 $2.81 $2.81 $2.64 $2.65 1 539 657
2021-07-13 $2.80 $2.85 $2.76 $2.84 2 141 240
2021-07-12 $2.92 $2.94 $2.82 $2.88 859 240
2021-07-09 $2.94 $2.94 $2.87 $2.92 516 041
2021-07-08 $2.81 $2.93 $2.79 $2.91 708 064
2021-07-07 $2.94 $2.97 $2.82 $2.92 1 391 007
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT